{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:08:48Z","timestamp":1777860528162,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.arcmed.2025.103238","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T17:36:11Z","timestamp":1747762571000},"page":"103238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Comprehensive Review of Behcet\u2019s Disease Damage Assessment Tools"],"prefix":"10.1016","volume":"56","author":[{"given":"Alireza","family":"Khabbazi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1476-6915","authenticated-orcid":false,"given":"Ehsan","family":"Mehrtabar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saba","family":"Mehrtabar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9909-1683","authenticated-orcid":false,"given":"Amirreza","family":"Khalaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aida","family":"Malek Mahdavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2025.103238_bib0001","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/ar2745","article-title":"Outcome measures in inflammatory rheumatic diseases","volume":"11","author":"Fransen","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.arcmed.2025.103238_bib0002","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.rdc.2010.04.001","article-title":"Outcome measures in ANCA-associated vasculitis","volume":"36","author":"Suppiah","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.arcmed.2025.103238_bib0003","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.3899\/jrheum.141147","article-title":"Current status, goals, and research agenda for outcome measures development in Beh\u00e7et syndrome: report from OMERACT 2014","volume":"42","author":"Hatemi","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.arcmed.2025.103238_bib0004","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/MD.0b013e318211bf28","article-title":"Beh\u00e7et disease: evolution of clinical manifestations","volume":"90","author":"Ideguchi","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.arcmed.2025.103238_bib0005","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s10067-019-04570-w","article-title":"Beh\u00e7et\u2019s disease in Egypt: a multicenter nationwide study on 1526 adult patients and review of the literature","volume":"38","author":"Gheita","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.arcmed.2025.103238_bib0006","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1080\/14397595.2021.1886623","article-title":"Long-term outcome and predictors of remission in Beh\u00e7et\u2019s disease in daily practice","volume":"31","author":"Malek Mahdavi","year":"2021","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.arcmed.2025.103238_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109341","article-title":"Outcome measures in Beh\u00e7et syndrome","volume":"251","author":"Hatemi","year":"2023","journal-title":"Clin Immunol"},{"key":"10.1016\/j.arcmed.2025.103238_bib0008","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3899\/jrheum.131249","article-title":"Outcome measures used in clinical trials for Beh\u00e7et syndrome: a systematic review","volume":"41","author":"Hatemi","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.arcmed.2025.103238_bib0009","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3109\/s10165-009-0191-z","article-title":"Comparison of existing disease activity indices in the follow-up of patients with Beh\u00e7et\u2019s disease","volume":"19","author":"Shahram","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.arcmed.2025.103238_bib0010","doi-asserted-by":"crossref","first-page":"A491","DOI":"10.1136\/annrheumdis-2013-eular.1474","article-title":"Predictive factors of long-term clinical outcome in patients with ocular involvement secondary to Behcet\u2019s disease","volume":"72","author":"Ferrari","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arcmed.2025.103238_bib0011","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10067-018-4344-3","article-title":"Evaluation of treatment adherence in patients with Beh\u00e7et\u2019s disease: its relation to disease manifestations, patients\u2019 beliefs about medications, and quality of life","volume":"38","author":"Zayed","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.arcmed.2025.103238_bib0012","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1080\/14397595.2021.1886623","article-title":"Long-term outcome and predictors of remission in Behcet\u2019s disease in daily practice","volume":"31","author":"Malek Mahdavi","year":"2021","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.arcmed.2025.103238_bib0013","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/art.1780400222","article-title":"Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides","volume":"40","author":"Exley","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arcmed.2025.103238_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001192","article-title":"Development and preliminary validation of the Beh\u00e7et\u2019s syndrome Overall Damage Index (BODI)","volume":"6","author":"Piga","year":"2020","journal-title":"RMD Open"},{"key":"10.1016\/j.arcmed.2025.103238_bib0015","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/1756-185X.14166","article-title":"Development and validation of a Beh\u00e7et\u2019s Disease Damage Index for adults with BD: an explicit, composite and rated (ECR) tool","volume":"24","author":"Gheita","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.arcmed.2025.103238_bib0016","first-page":"275","article-title":"VITAL (Vasculitis Integrated Assessment Log) assessment of vasculitis","volume":"13","author":"Bacon","year":"1995","journal-title":"Clin Exp Rheumatol"},{"issue":"suppl 9","key":"10.1016\/j.arcmed.2025.103238_bib0017","first-page":"S340","article-title":"The Vasculitis Damage Index (abstract)","volume":"38","author":"Exley","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arcmed.2025.103238_bib0018","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/ard.2009.122952","article-title":"Measurement of damage in systemic vasculitis: a comparison of the vasculitis damage index with the combined damage assessment index","volume":"70","author":"Suppiah","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arcmed.2025.103238_bib0019","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1007\/s11845-022-03260-y","article-title":"Validity and reliability of the BODI for assessing damage in Behcet\u2019s disease","volume":"192","author":"Musavian","year":"2023","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.arcmed.2025.103238_bib0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s42358-021-00193-5","article-title":"Vasculitis damage index in Beh\u00e7et\u2019s disease","volume":"61","author":"Elgengehy","year":"2021","journal-title":"Adv Rheumatol"},{"key":"10.1016\/j.arcmed.2025.103238_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.reuma.2019.03.002","article-title":"Quality of life in patients with Bechet disease and its relation with clinical symptoms and disease activity","volume":"17","author":"Khabbazi","year":"2021","journal-title":"Reumatol Clin (Engl Ed)"},{"key":"10.1016\/j.arcmed.2025.103238_bib0022","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/art.1780400222","article-title":"Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides","volume":"40","author":"Exley","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arcmed.2025.103238_bib0023","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1136\/annrheumdis-2016-210092","article-title":"Development of the autoinflammatory disease damage index (ADDI)","volume":"76","author":"Ter Haar","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arcmed.2025.103238_bib0024","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/art.1780390303","article-title":"The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for systemic lupus erythematosus","volume":"39","author":"Gladman","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arcmed.2025.103238_bib0025","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3899\/jrheum.131310","article-title":"Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of \u201ctruth\u201d: content, face, and construct validity","volume":"41","author":"Tugwell","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.arcmed.2025.103238_bib0026","doi-asserted-by":"crossref","DOI":"10.1177\/20406223221111285","article-title":"Effectiveness and safety of low-dose interferon alpha-2a treatment in Behcet\u2019s Syndrome with refractory vascular or neurological involvement: a case series","volume":"13","author":"Sun","year":"2022","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.arcmed.2025.103238_bib0027","article-title":"The effect of cigarette smoking on Behcet\u2019s disease outcomes: a multicentre study","author":"Alikhani","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.arcmed.2025.103238_bib0028","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s40123-024-00916-z","article-title":"Ocular manifestations in juvenile Behcet\u2019s disease: a registry-based analysis from the AIDA network","volume":"13","author":"Gaggiano","year":"2024","journal-title":"Ophthalmol Ther"},{"issue":"3","key":"10.1016\/j.arcmed.2025.103238_bib0029","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/rheumatology\/keae266","article-title":"Validation of the Beh\u00e7et\u2019s Syndrome Overall Damage Index (BODI) for retrospective studies and a proposal for modification","volume":"64","author":"Ozogul","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.arcmed.2025.103238_bib0030","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s13075-022-02947-y","article-title":"Accrual of organ damage in Beh\u00e7et\u2019s syndrome: trajectory, associated factors, and impact on patients\u2019 quality of life over a 2\u2011year prospective follow\u2011up study","volume":"24","author":"Floris","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.arcmed.2025.103238_bib0031","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/rheumatology\/kead681","article-title":"Organ damage is a major determinant of work productivity impairment in Beh\u00e7et\u2019s Syndrome: a post-hoc analysis of the BODI validation study","volume":"64","author":"Floris","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.arcmed.2025.103238_bib0032","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10067-021-05991-2","article-title":"Hafeez Moshrif Aet al. Computed tomography pulmonary angiography (CTPA) in Beh\u00e7et\u2019s disease patients: a remarkable gender gap and time to refine the treatment strategy","volume":"41","author":"Tharwat","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.arcmed.2025.103238_bib0033","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/1756-185X.14705","article-title":"Damage accrual in Beh\u00e7et disease: beh\u00e7et\u2019s Syndrome overall Damage Index (BODI) versus Beh\u00e7et\u2019s Disease Damage Index (BDI)","volume":"26","author":"Hassan","year":"2023","journal-title":"Int J Rheum Dis"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018844092500058X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018844092500058X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:54:54Z","timestamp":1758765294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S018844092500058X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S018844092500058X"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2025.103238","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Comprehensive Review of Behcet\u2019s Disease Damage Assessment Tools","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2025.103238","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103238"}}